ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PRTC Puretech Health Plc

219.00
5.00 (2.34%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 2.34% 219.00 218.00 219.00 224.50 214.00 214.00 837,599 16:29:47
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 23.75M -50.35M -0.1839 -11.91 599.77M
Puretech Health Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 214p. Over the last year, Puretech Health shares have traded in a share price range of 139.00p to 242.00p.

Puretech Health currently has 273,866,153 shares in issue. The market capitalisation of Puretech Health is £599.77 million. Puretech Health has a price to earnings ratio (PE ratio) of -11.91.

Puretech Health Share Discussion Threads

Showing 1651 to 1674 of 2000 messages
Chat Pages: Latest  68  67  66  65  64  63  62  61  60  59  58  57  Older
DateSubjectAuthorDiscuss
11/1/2024
16:53
These UT trades at the end of each day are relentless :-(
return_of_the_apeman
11/1/2024
13:47
feels like we are walked down by market makers. seems odd given our new found very strong balance sheet. i have added on the dip..
edwardt
11/1/2024
10:20
Plenty of smaller holders clearly wanted more immediate returns and are exiting - nice to hear the longer term plan seems to be on track :)
takeiteasy
11/1/2024
08:33
At JPM CEO called 100pc owned Seaport 'Karuna on steroids'.set up by the original Karuna team.I would expect pre IPO money from the institutions who have made billions from Karuna.Seaport certainly has the potential to become a $14bn company in coming years.this time around Puretech will be in position to have a much bigger slice of a very big pie.
colinblackbourn
11/1/2024
05:35
Just looking at the chart 200 does seem more of a support than a resistance point, 250 may be more of a resistance point. This share has caused a lot of pain for holders over many years so there is not much love around at all yet and some looking for early exits - if this a much better year for biotech in general we may get an improved performance from the underlying businesses and more confidence from the market in this share - won't happen overnight I guess...
takeiteasy
10/1/2024
22:57
Doctor 69.
We did. Then we dropped.
We might go back up again tomorrow.

daijavu
10/1/2024
21:31
Vor up 22% - looks like there might be value there...
edwardt
10/1/2024
10:22
We usually go up in the afternoon as usa opens
doctor 69
10/1/2024
09:25
At which point we will know their new "capital returns strategy"

Watching the chart back test of £2

return_of_the_apeman
10/1/2024
08:32
According to the presentation the Karuna stake will be held until the deal closes in a couple of months which gives the full $330 per share.$294m.they already have $320m
colinblackbourn
10/1/2024
07:53
Presenting this afternoon in the US. Hopefully we will get some more information on how it went over the next couple of days.
wildchild
10/1/2024
07:50
Agree steady controlled rise . Well if 2023 was awful year for biotechs , once market turns it will be quality stocks like pure that will shine . The poor market of 2023 has given us a chance to pick up pure stock on the cheap . Upside looks very large and if market moves positively as interest rates get cut , then pure will deliver us big returns .
doctor 69
10/1/2024
07:41
There is a very interesting narrative in the BBH trust monthly update today about why 2023 went so horribly wrong for even the best biotechs - nothing we don't know of course but a useful reminder of the impact of certain key issues on investor sentiment.
This stock feels like it is being very tightly controlled, tiny move by tiny move to avoid any jumps for short term traders to join the party. Just my hunch but we seem to be heading in the right direction at the moment little by little...dyor etc

takeiteasy
10/1/2024
03:27
It has just followed the XBI, down down down no matter what the quality of the company. Does leave an awful lot of upside though, when sentiment towards the sector turns more favourable.
rambutan2
09/1/2024
19:39
ok, got you.

Presentation is excellent with an interesting mental health treatment under development.. you only have to wonder where this has gone so wrong with such a sensible strategy and strong management.

takeiteasy
09/1/2024
19:01
Actually since January 2021 takeiteasy when puretech hit 420
brianblu
09/1/2024
17:26
I wonder if the large trade done later this afternoon has been holding us back - perhaps we will find out tomorrow - would be good if we can break out of the consistent down channel chart trend (above) from early 2023...
takeiteasy
09/1/2024
12:44
https://puretechhealth.com/images/PRTCCorpPresentation.pdf
colinblackbourn
09/1/2024
12:27
When you look at the 7 year chart puretech is still well below the median considering the latest developments,it was just so undervalued under £2
linton5
08/1/2024
20:42
Peel hunt are smoking the good stuff. Let's get to £2.50 first
edwardt
08/1/2024
19:35
Puretech Already stated y/e net cash will be $320m.892000 Karuna left.$282m value now or $294m on closing.$400m milestones to come.plus maybe another.$200m..$320m$294m$400m$200m$1214m272m shares in issue.351p per share cash.Milestones are payable over a period of years Not sure of the tax position Multiple Karuna like opportunities in the pipeline Peel Hunt has a 930p target
colinblackbourn
08/1/2024
17:14
PureTech Health plcPureTech to Present at 42(nd) Annual J.P. Morgan Healthcare ConferencePureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Daphne Zohar, Founder and Chief Executive Officer, will present at the 42(nd) Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:00 a.m. PST / 12:00 p.m. EST. A webcast of the presentation will be available at https://investors.puretechhealth.com.
colinblackbourn
08/1/2024
17:12
The 42nd Annual Healthcare Conference will take place on January 8-11, 2024 in San Francisco, CA.This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
colinblackbourn
08/1/2024
17:08
Its a medical conference, surely more likely to hear about updates regarding the drugs pipeline! Details regarding cash return policy should simply be via an RNS at an appropriate time i.e when the deal completes or goes unconditional
rimau1
Chat Pages: Latest  68  67  66  65  64  63  62  61  60  59  58  57  Older

Your Recent History

Delayed Upgrade Clock